NASDAQ · Medical - Devices

LFWD (LFWD) Stock

$7.00 -1.41% NASDAQ: LFWD Healthcare

Valuation

MetricValue
Price$7.00
Market Cap$11.28M
P/E Ratio-0.39
P/B Ratio1.28
P/S Ratio0.46
EPS (TTM)$-17.16
52-Week High$12.60
52-Week Low$4.14
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-250.00%
ROA-86.96%
ROCE-188.89%
Gross Margin-77.27%
Operating Margin-77.27%
Net Margin-1.24%
Debt/Equity1.40
Current Ratio1.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$6.0M$14.0M$26.0M$22.0M
Operating Profit$-13.0M$-19.0M$-24.0M$-20.0M$-17.0M
Net Profit$-13.0M$-20.0M$-22.0M$-29.0M$-20.0M
EPS$-22.32$-26.40$-31.08$-39.96$-17.16
Op Margin-212.1%-346.6%-170.4%-76.2%-76.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$95.0M$74.0M$63.0M$30.0M$23.0M
Total Liabilities$5.0M$6.0M$17.0M$12.0M$14.0M
Cash$88.0M$68.0M$28.0M$7.0M$2.0M
Borrowings$1.0M$1.0M$2.0M$1.0M$2.0M

Latest News

Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board GlobeNewswire · Jul 21, 2026 Lifeward Enters Securities Purchase Agreement Under Oramed Financing Framework MT Newswires · Jul 7, 2026 Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing GlobeNewswire · Jul 7, 2026 Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform GlobeNewswire · May 19, 2026 How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions Simply Wall St. · May 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-18.0M$-21.0M$-22.0M$-17.0M
Investing Cash Flow$0$0$-18.0M$0$0
Financing Cash Flow$15.0M$-2.0M$-1.0M$0$2.0M
Net Cash Flow$68.0M$-20.0M$-40.0M$-22.0M$-5.0M
Free Cash Flow$-12.0M$-18.0M$-21.0M$-22.0M$-17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-156.98%
Quick Ratio1.82
Interest Coverage—
Return 1Y-10.35%
Return 3Y-88.20%
Return 5Y-93.36%

Ownership

Insiders Held47.45%
Institutions Held0.79%
Institutions Float Held1.50%
Institutional HolderSharesReport Date
Renaissance Technologies, LLC11,4272026-03-31
UBS Group AG2,1252026-03-31
SBI Securities Co., Ltd.1962026-03-31
Morgan Stanley2082026-03-31
Osaic Holdings Inc.1072026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DHAIDIH Holding US, Inc. $0.02 +0.00% 0.00 $41853 0.00%
IINNInspira Technologies OXY B.H.N. Ltd. $1.26 -5.97% -2.80 $30.34M 0.00%
INAB $1.19 -0.83% -0.35 $11.41M 0.00%
LYRALyra Therapeutics, Inc. $0.52 +0.00% -0.03 $922939 0.00%
PTHLPheton Holdings Ltd Class A Ordinary Shares $0.28 -5.73% -0.92 $4.09M 0.00%

About LFWD

LFWD is led by CEO William Mark Grant, employs 80 people, headquartered in IL, publicly traded since 2014.

LFWD stock trades at $7.00 with a market capitalization of $11.28M. The stock is valued at a price-to-earnings (P/E) ratio of -0.39, price-to-book of 1.28, price-to-sales of 0.46. Over the past 52 weeks the stock has ranged between $4.14 and $12.60, and currently trades 44.4% below its 52-week high.

On profitability, LFWD generates a return on equity (ROE) of -250.00%, return on capital employed of -188.89%, an operating margin of -77.27%, a net profit margin of -1.24%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides